5 Amendments of Fiona HALL related to 2012/2135(INI)
Amendment 20 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Underlines the fact that, although there is no general definition of the term ‘biopiracy’, it usuallmay refers to the industrial practice of privatising and patenting products based on the traditional knowledge or genetic resources of indigenous peoples, without authorisation or providing compensation to source countries;
Amendment 32 #
Motion for a resolution
Paragraph 10
Paragraph 10
10. Points out that three quarters of the plants used in modern medicine come from traditional medicine; believes that biopiracy means there is a strong case for protecting traditional knowledge, particularly when it is associated with genetic resources of economic value to the pharmaceuticals industry;
Amendment 39 #
Motion for a resolution
Paragraph 14
Paragraph 14
14. Stresses that the CBD's objectives will only be attained if fair and equitable sharing of benefits is granted; urges the EU and its Member States to call for swift ratification of the Nagoya Protocol in order to combat biopiracy and restorenhance fairness and equity in the exchange of genetic resources; stresses the role of EU development cooperation in providing developing countries with assistance with legal and institutional capacity-building on access and benefit sharing issues;
Amendment 40 #
Motion for a resolution
Paragraph 14 a (new)
Paragraph 14 a (new)
14 a. Stresses the role of EU development cooperation in providing developing countries with assistance for legal and institutional capacity-building on access and benefit sharing issues; believes that support should be given to developing countries in building up databases of TK and understanding patent application systems;
Amendment 44 #
Motion for a resolution
Paragraph 16
Paragraph 16
16. Regrets the lack of clear statistics on biopiracy and misappropriation, and calls on the EU to support the setting up of an independent bodyfor more EU research in this field to remedy this situation;